Isomorphic Labs Just Made $2.1 Billion Obsolete as a Number: The Real Bet Is on What Comes After Phase 2
Isomorphic Labs' $2.1B raise signals AI drug discovery has crossed from hype to pipeline — and traditional pharma R&D...
Computational Biology
The $4 Billion AI Drug Discovery Bet Has a Hidden Ceiling No One Is Pricing In
AI drug discovery attracted $4B in 2024 VC funding, but Phase 3 attrition, payer skepticism, and regulatory opacity threaten...